Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies.

CONCLUSION: EUS-guided biopsy sampling is accurate for the pretreatment diagnosis and characterization of GISTs and allows the prediction and evaluation of tumor response to neoadjuvant imatinib therapy. PMID: 28932084 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28932084?dopt=Abstract

Source: World Journal of Gastroenterology : WJG - August 28, 2017 Category: Gastroenterology Authors: Hedenström P, Nilsson B, Demir A, Andersson C, Enlund F, Nilsson O, Sadik R Tags: World J Gastroenterol Source Type: research